AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

14,112.00p
   
  • Change Today:
      74.00p
  • 52 Week High: 14,258.00
  • 52 Week Low: 9,667.00
  • Currency: UK Pounds
  • Shares Issued: 1,550.91m
  • Volume: 267,461
  • Market Cap: £218,864m
  • RiskGrade: 123
  • Beta: 1.23

Latest Deals

Traded Action Notifier PriceAmountValue
18-Dec-25 Sell Nazneen Rahman 13,496.00p 297 £40,083.12

Largest Deals (28 days)

Traded Action Notifier PriceAmountValue
18-Dec-25 Sell Nazneen Rahman 13,496.00p 297 £40,083.12

Director Shareholdings

Notifier Holding Value*
Pascal Soriot 746,354 £105,325,476
Aradhana Sarin 93,804 £13,237,620
Marcus Wallenberg 60,028 £8,471,151
Philip A J Broadley 19,495 £2,751,134
Michel Demare 10,000 £1,411,200
Tony Mok 3,500 £493,920
Sheri McCoy 1,736 £244,984
Karen Knudsen 1,405 £198,274
Diana Layfield 1,400 £197,568
Euan Ashley 1,150 £162,288
Nazneen Rahman 720 £101,606
Anna Manz 487 £68,725

Major Shareholders

Notifier** Holding Value*
BlackRock, Inc 100,885,181 £14,236,916,743
Oddo Meriten Asset Management SA 100,885,181 £14,236,916,743
The Capital Group Companies, Inc. 77,125,348 £10,883,929,110
Wellington Management Company LLP 65,118,411 £9,189,510,160
Investor AB 51,587,810 £7,280,071,747

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 14,112.00p
Change Today 74.00p
% Change 0.53 %
52 Week High 14,258.00
52 Week Low 9,667.00
Volume 267,461
Shares Issued 1,550.91m
Market Cap £218,864m
Beta 1.23
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average
90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average
Price Trend
9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average
45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average
Income
68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 10
Buy 13
Neutral 3
Sell 0
Strong Sell 1
Total 27
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 07-Aug-25 20-Feb-25
Paid 08-Sep-25 24-Mar-25
Amount 103.00¢ 210.00¢

Trades for 07-Jan-2026

Time Volume / Share Price
11:38 47 @ 14,112.00p
11:38 22 @ 14,112.00p
11:38 7 @ 14,112.00p
11:38 12 @ 14,114.00p
11:38 20 @ 14,114.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page